• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Esperion Therapeutics, Inc. - Common Stock (NQ:ESPR)

3.160 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 3.160 (6,500)
Ask (Size) 3.170 (115,600)
Prev. Close 3.160
Today's Range 3.160 - 3.160
52wk Range 1.100 - 4.175
Shares Outstanding 28,277,493
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Esperion Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Esperion Therapeutics, Inc. - ESPR
June 17, 2026
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Esperion Presents New Data from CLEAR Outcomes and the CLEAR PATH Phase 2 Pediatric Study at the European Atherosclerosis Society Congress 2026
May 26, 2026
From Esperion Therapeutics, Inc.
Via GlobeNewswire

Performance

YTD
-14.8%
-14.8%
1 Month
+1.0%
+1.0%
3 Month
+23.9%
+23.9%
6 Month
-17.1%
-17.1%
1 Year
+184.7%
+184.7%

More News

Read More
News headline image
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 14, 2026
From Esperion Therapeutics, Inc.
Via GlobeNewswire
News headline image
Esperion Announces Two New Analyses Supporting Bempedoic Acid to Reduce LDL-C Levels to be Presented at the European Atherosclerosis Society (EAS) Congress 2026
May 13, 2026
From Esperion Therapeutics, Inc.
Via GlobeNewswire
Friday's session: most active stocks ↗
May 01, 2026
Via Chartmill
Esperion Therapeutics Inc (NASDAQ:ESPR) Reports Mixed Q4 2025 Results Amid Strategic Expansion ↗
March 10, 2026
Via Chartmill
News headline image
Halper Sadeh LLC is Investigating Whether SILA, ESPR, CRBG, EQH are Obtaining Fair Deals for their Shareholders
May 06, 2026
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether SILA, LSTA, ESPR are Obtaining Fair Deals for their Shareholders
May 05, 2026
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Esperion Therapeutics, Inc. (Nasdaq – ESPR), Sila Realty Trust, Inc. (NYSE – SILA), Lisata Therapeutics, Inc. (Nasdaq – LSTA), SkyWater Technology, Inc. (Nasdaq -
May 05, 2026
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Esperion Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Esperion Therapeutics, Inc. - ESPR
May 04, 2026
From Kahn Swick & Foti, LLC
Via Business Wire
What's going on in today's session ↗
May 01, 2026
Via Chartmill
News headline image
Veeva Systems, Five9, AXT And Other Big Stocks Moving Higher On Friday ↗
May 01, 2026
Via Benzinga
Topics Artificial Intelligence Stocks
Which stocks are moving on Friday? ↗
May 01, 2026
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
May 01, 2026
Via Chartmill
News headline image
ESPR Stock Alert: Halper Sadeh LLC is Investigating Whether Esperion Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders
May 01, 2026
From Halper Sadeh LLC
Via Business Wire
Stay updated with the stocks that are on the move in today's pre-market session. ↗
May 01, 2026
Via Chartmill
News headline image
Esperion to be Acquired by ARCHIMED
May 01, 2026
From Esperion Therapeutics, Inc.
Via GlobeNewswire
News headline image
Esperion to Report First Quarter 2026 Financial Results on May 7
April 23, 2026
From Esperion Therapeutics, Inc.
Via GlobeNewswire
News headline image
Athyrium Capital Management and Esperion Enter Into $50 Million Japan Royalty Financing to Support Strategic Acquisition of Corstasis Therapeutics
April 02, 2026
From Athyrium Capital Management, LP
Via GlobeNewswire
News headline image
Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)
April 02, 2026
From Esperion Therapeutics, Inc.
Via GlobeNewswire
News headline image
Esperion to Participate in 25th Annual Needham Virtual Healthcare Conference
March 31, 2026
From Esperion Therapeutics, Inc.
Via GlobeNewswire
News headline image
Esperion Showcases New Data from CLEAR Outcomes Highlighting Value of NEXLETOL® (bempedoic acid) at the American College of Cardiology’s Annual Scientific Session 2026
March 30, 2026
From Esperion Therapeutics, Inc.
Via GlobeNewswire
News headline image
Esperion to Present Two New Analyses from CLEAR Outcomes Clinical Trial at the American College of Cardiology 2026 Annual Scientific Session
March 17, 2026
From Esperion Therapeutics, Inc.
Via GlobeNewswire
News headline image
Esperion’s Bempedoic Acid Receives Multiple Class 1 Recommendations in 2026 ACC/AHA Multisociety Guideline for Management of Dyslipidemia
March 16, 2026
From Esperion Therapeutics, Inc.
Via GlobeNewswire
News headline image
ESPR Stock Falls After Esperion’s Mixed Q4 — Retail Remains Unfazed, Eyes ‘Massive’ Upcoming Catalysts ↗
March 10, 2026
Via Stocktwits
Topics Intellectual Property

Frequently Asked Questions

Is Esperion Therapeutics, Inc. - Common Stock publicly traded?
Yes, Esperion Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Esperion Therapeutics, Inc. - Common Stock trade on?
Esperion Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Esperion Therapeutics, Inc. - Common Stock?
The ticker symbol for Esperion Therapeutics, Inc. - Common Stock is ESPR on the Nasdaq Stock Market
What is the current price of Esperion Therapeutics, Inc. - Common Stock?
The current price of Esperion Therapeutics, Inc. - Common Stock is 3.160
When was Esperion Therapeutics, Inc. - Common Stock last traded?
The last trade of Esperion Therapeutics, Inc. - Common Stock was at 07/02/26 04:00 PM ET
What is the market capitalization of Esperion Therapeutics, Inc. - Common Stock?
The market capitalization of Esperion Therapeutics, Inc. - Common Stock is 89.36M
How many shares of Esperion Therapeutics, Inc. - Common Stock are outstanding?
Esperion Therapeutics, Inc. - Common Stock has 89M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap